Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosis

J Neuroimmunol. 2002 Dec;133(1-2):233-40. doi: 10.1016/s0165-5728(02)00372-7.

Abstract

Sympathoadrenergic mechanisms may play a role in multiple sclerosis (MS). We examined catecholamine (CA) levels and production and tyrosine hydroxylase (TH) expression in peripheral blood mononuclear cells (PBMCs) from MS patients, and the correlation between CA production and apoptosis in PBMCs. PBMCs from MS patients had increased norepinephrine (NE) levels. However, phytohaemagglutinin (PHA)-stimulated PBMCs from MS patients with active disease synthesized less dopamine (DA) than cells from both healthy controls and patients with inactive disease. PBMCs from patients with inactive disease showed lower expression of TH. Pharmacological inhibition of TH in cultured PBMCs stimulated with PHA reduced the percentage of apoptotic cells. Since a failure of activation-induced apoptosis in immune cells may be involved in MS, it is suggested that altered CA production by PBMCs may be implicated in such dysregulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Apoptosis / immunology*
  • Catecholamines / biosynthesis*
  • Catecholamines / immunology
  • Enzyme Inhibitors / pharmacology
  • Female
  • Humans
  • Leukocytes, Mononuclear / enzymology
  • Leukocytes, Mononuclear / immunology*
  • Lymphocyte Activation / immunology*
  • Male
  • Middle Aged
  • Multiple Sclerosis / blood
  • Multiple Sclerosis / enzymology
  • Multiple Sclerosis / immunology*
  • Neuroimmunomodulation / immunology
  • Sympathetic Nervous System / immunology
  • Tyrosine 3-Monooxygenase / antagonists & inhibitors
  • Tyrosine 3-Monooxygenase / metabolism*
  • alpha-Methyltyrosine / pharmacology

Substances

  • Catecholamines
  • Enzyme Inhibitors
  • alpha-Methyltyrosine
  • Tyrosine 3-Monooxygenase